Search Results - "Funck, L"

High MBL-expressing genotypes are associated with deterioration in renal function in type 2 diabetes by Dørflinger, G H, Høyem, P H, Laugesen, E, Østergaard, J A, Funck, K L, Steffensen, R, Poulsen, P L, Hansen, T K, Bjerre, M

“…Accumulating evidence support that mannan-binding lectin (MBL) is a promising prognostic biomarker for risk-stratification of diabetic micro- and macrovascular…”
Get full text

Heterogeneity of fern communities in riparian forest remnants from the South Brazilian Campos (Pampa) by Silva, V L, Orlandi, C R, Funck, L, Winhelmann, M C, Schmitt, J L, Fior, C S, Freitas, E M

“…Riparian forests present biotic and abiotic factors that influence environmental dissimilarity, which reflect specific fern distribution. The purpose of this…”
Get full text

Arterial stiffness and progression of cerebral white matter hyperintensities in patients with type 2 diabetes and matched controls: a 5-year cohort study by Funck, Kristian L, Laugesen, Esben, Hayem, Pernille, Stausbal-Gran, Brian, Kim, Won Y, Østergaard, Leif, Grauballe, Dora, Hansen, Troels K, Buhl, Christian S, Poulsen, Per L

“…Abstract Background Stroke is a serious complication in patients with type 2 diabetes (T2DM). Arterial stiffness may improve stroke prediction. We investigated…”
Get full text

Coronary plaque burden in Turner syndrome a coronary computed tomography angiography study by Funck, Kristian L., Budde, Ricardo P. J., Viuff, Mette H., Wen, Jan, Jensen, Jesper M., Nørgaard, Bjarne L., Bons, Lidia R., Duijnhouwer, Anthonie L., Dey, Damini, Mortensen, Kristian H., Andersen, Niels H., Roos-Hesselink, Jolien W., Gravholt, Claus H.

“…Turner syndrome (TS) is associated with coronary artery disease (CAD), an important cause of premature death in TS. However, the determinants of CAD in women…”
Get full text

Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial by Gullaksen, Søren, Vernstrøm, Liv, Sørensen, Steffen S., Ringgaard, Steffen, Laustsen, Christoffer, Funck, Kristian L., Poulsen, Per L., Laugesen, Esben

“…Aims/hypothesis Glucagon-like peptide-1 receptor agonists (GLP-1ras) and sodium–glucose cotransporter 2 inhibitors (SGLT2is) have shown kidney-protective…”
Get full text

Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial by Gullaksen, Søren, Vernstrøm, Liv, Sørensen, Steffen S., Ringgaard, Steffen, Laustsen, Christoffer, Funck, Kristian L., Poulsen, Per L., Laugesen, Esben

Get full text

Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial by Vernstrøm, Liv, Gullaksen, Søren, Sørensen, Steffen S., Ringgaard, Steffen, Laustsen, Christoffer, Birn, Henrik, Funck, Kristian L., Laugesen, Esben, Poulsen, Per L.

“…Aims/hypothesis The apparent diffusion coefficient (ADC) derived from diffusion-weighted MRI (DWI-MRI) has been proposed as a measure of changes in kidney…”
Get full text

Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial by Vernstrøm, Liv, Gullaksen, Søren, Sørensen, Steffen S., Funck, Kristian L., Laugesen, Esben, Poulsen, Per L.

“…Aim Despite the increasing use of combination treatment with sodium‐glucose cotransporter 2 inhibitors and glucagon‐like peptide‐1 receptor agonists, data are…”
Get full text

Evaluation of renal oxygenation by BOLD–MRI in high-risk patients with type 2 diabetes and matched controls by Sørensen, Steffen S, Gullaksen, Søren, Vernstrøm, Liv, Ringgaard, Steffen, Laustsen, Christoffer, Funck, Kristian L, Laugesen, Esben, Poulsen, Per L

“…ABSTRACT Background Diabetic kidney disease (DKD) accounts for ∼50% of end-stage kidney disease. Renal hypoxia is suggested as a main driver in the…”
Get full text

Real‐world use of cardioprotective glucose‐lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019 by Funck, Kristian L., Knudsen, Jakob S., Hansen, Troels K., Thomsen, Reimar W., Grove, Erik L.

“…Aims To investigate temporal trends in time to initiation of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide 1 analogues (cardioprotective…”
Get full text

The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial by Gullaksen, Søren, Vernstrøm, Liv, Sørensen, Steffen S., Ringgaard, Steffen, Laustsen, Christoffer, Birn, Henrik, Funck, Kristian L., Poulsen, Per L., Laugesen, Esben

“…To evaluate the effect of treatment with semaglutide and empagliflozin on the cortico-medullary sodium gradient (MCR; medulla/cortex ratio), urine…”
Get full text

Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease by Risikesan, Jeyanthini, Heebøll, Sara, Kumarathas, Indumathi, Funck, Kristian L., Søndergaard, Esben, Johansen, Rakel F., Ringgaard, Steffen, Tolbod, Lars P., Johannsen, Mogens, Kanstrup, Helle L., Grønbæk, Henning, Frystyk, Jan, Gormsen, Lars C., Nielsen, Søren

“…Metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with dyslipidemia and may promote cardiac lipotoxicity. Myocardial free fatty acids…”
Get full text

Feasibility of Arteriograph 24 for evaluation of 24-hour pulse wave velocity and central blood pressure in patients with type 2 diabetes and non-diabetic controls by Laugesen, Esben, Svendsen, Amalie Nørkjær, Vernstrøm, Liv, Halkjær, Lene, Dons-Jensen, Anna, Funck, Kristian L, Hansen, Klavs Würgler, Poulsen, Per Løgstrup

“…The objective of this study was to assess the feasibility of the Arteriograph 24 device to measure 24-hour PWV and central systolic blood pressure (cSBP) in…”
Get full text

Increased high-risk coronary plaque burden is associated with arterial stiffness in patients with type 2 diabetes without clinical signs of coronary artery disease: a computed tomography angiography study by Funck, Kristian L, Laugesen, Esben, Øvrehus, Kristian, Jensen, Jesper M, Nørgaard, Bjarne L, Dey, Damini, Hansen, Troels K, Poulsen, Per L

“…Arterial stiffness and subclinical coronary atherosclerosis may yield valuable information on cardiovascular risk. We aimed to characterize coronary…”
Get full text

Low Physical Activity Is Associated With Increased Arterial Stiffness in Patients Recently Diagnosed With Type 2 Diabetes by Funck, Kristian L., Laugesen, Esben, Høyem, Pernille, Fleischer, Jesper, Cichosz, Simon L., Christiansen, Jens S., Hansen, Troels K., Poulsen, Per L.

“…AIMS Several studies have indicated that low physical activity is associated with increased risk of cardiovascular disease (CVD) and all-cause mortality among…”
Get full text

Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetes by Vernstrøm, L., Laugesen, E., Grove, E. L., Baier, J. M., Gullaksen, S., Hvas, A.‐M., Poulsen, P. L., Funck, K. L.

“…Aim We investigated whether the effect of low‐dose aspirin on endothelium‐dependent vasodilation and arterial stiffness in people with Type 2 diabetes is…”
Get full text

Plasma levels of MASP‐1, MASP‐3 and MAp44 in patients with type 2 diabetes: influence of glycaemic control, body composition and polymorphisms in the MASP1 gene by Krogh, S. S., Holt, C. B., Steffensen, R., Funck, K. L., Høyem, P., Laugesen, E., Poulsen, P. L., Thiel, S., Hansen, T. K.

“…Summary Mounting evidence indicates that adverse activation of the complement system plays a role in the development of diabetic vascular complications. Plasma…”
Get full text

6.3 ARTERIAL STIFFNESS IS ASSOCIATED WITH LOW-DENSITY NON-CALCIFIED CORONARY PLAQUES IN PATIENTS WITH TYPE 2 DIABETES AND HEALTHY CONTROLS by Funck, Kristian L., Laugesen, Esben, Oevrehus, Kristian, Jensen, Jesper M., Noergaard, Bjarne L., Dey, Damini, Hansen, Troels K., Poulsen, Per L.

“…Background: Arterial stiffness may provide non-invasive information about cardiovascular risk in patients with type 2 diabetes. We investigated the association…”
Get full text

High burden of coronary atherosclerosis in patients with a new diagnosis of type 2 diabetes by Mrgan, Monija, Funck, Kristian L, Gaur, Sara, Øvrehus, Kristian A, Dey, Damini, Kusk, Martin W, Nørgaard, Bjarne L, Gram, Jørgen B, Olsen, Michael H, Gram, Jeppe, Sand, Niels Peter R

“…The purposes of this study were to compare the presence, extent and composition of coronary plaques in asymptomatic patients with newly diagnosed type 2…”
Get more information

Heterogeneity of fern communities in riparian forest remnants from the South Brazilian Campos sul do Brasil by Silva, V.L, Orlandi, C.R, Funck, L, Winhelmann, M.C, Schmitt, J.L, Fior, C.S, Freitas, E.M

“…Riparian forests present biotic and abiotic factors that influence environmental dissimilarity, which reflect specific fern distribution. The purpose of this…”
Get full text